AU6896396A - Materials and methods for detection and treatment of insulin-dependent diabetes - Google Patents

Materials and methods for detection and treatment of insulin-dependent diabetes

Info

Publication number
AU6896396A
AU6896396A AU68963/96A AU6896396A AU6896396A AU 6896396 A AU6896396 A AU 6896396A AU 68963/96 A AU68963/96 A AU 68963/96A AU 6896396 A AU6896396 A AU 6896396A AU 6896396 A AU6896396 A AU 6896396A
Authority
AU
Australia
Prior art keywords
insulin
detection
treatment
materials
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU68963/96A
Inventor
Michael Lan
Quing Li
Noel K. Maclaren
Abner L. Noikins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
University of Florida
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/514,213 external-priority patent/US6391651B1/en
Priority claimed from US08/548,159 external-priority patent/US5989551A/en
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU6896396A publication Critical patent/AU6896396A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rehabilitation Therapy (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU68963/96A 1995-08-11 1996-08-09 Materials and methods for detection and treatment of insulin-dependent diabetes Abandoned AU6896396A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/514,213 US6391651B1 (en) 1995-08-11 1995-08-11 Materials and methods for detection of insulin dependent diabetes
US548159 1995-10-25
US08/548,159 US5989551A (en) 1995-10-25 1995-10-25 Materials and methods for detection and treatment of insulin-dependent diabetes
PCT/US1996/012935 WO1997007211A1 (en) 1995-08-11 1996-08-09 Materials and methods for detection and treatment of insulin-dependent diabetes
US514213 2000-02-25

Publications (1)

Publication Number Publication Date
AU6896396A true AU6896396A (en) 1997-03-12

Family

ID=27058143

Family Applications (1)

Application Number Title Priority Date Filing Date
AU68963/96A Abandoned AU6896396A (en) 1995-08-11 1996-08-09 Materials and methods for detection and treatment of insulin-dependent diabetes

Country Status (2)

Country Link
AU (1) AU6896396A (en)
WO (1) WO1997007211A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997022694A2 (en) * 1995-12-20 1997-06-26 Institute Of Molecular And Cell Biology Diagnostic reagents relating to diabetes
EP0929683A1 (en) 1996-03-06 1999-07-21 ZymoGenetics, Inc. DIABETES MELLITUS 37 kD AUTOANTIGEN PROTEIN-TYROSINE PHOSPHATASE
SE9704451D0 (en) * 1997-11-28 1997-11-28 Diamyd Therapeutics Ab New method and compositions for the treatment of autoimmune diseases
JP4594588B2 (en) * 2001-04-10 2010-12-08 ザ ボード オブ トラスティーズ オブ ザ リランド スタンフォード ジュニア ユニヴァーシティ Therapeutic and diagnostic uses of antibody-specific profiles
EP1632245A1 (en) * 2004-09-02 2006-03-08 Technische Universität Dresden Medizinische Fakultät Carl Gustav Carus ICA512 couples insulin secretion and gene expression in Beta-cells
EP1987837A1 (en) * 2007-05-02 2008-11-05 Technische Universität Dresden Medizinische Fakultät Carl Gustav Carus Pharmaceutical composition for increasing insulin secretion from pancreatic ß-cells

Also Published As

Publication number Publication date
WO1997007211A1 (en) 1997-02-27

Similar Documents

Publication Publication Date Title
AU5427996A (en) Process and crystal forms of 2-methyl-thieno-benzodiazepine
AU9040098A (en) Compounds and method for the prevention and treatment of diabetic retinopathy
AU5380498A (en) Casino table sensor alarms and method of using
AU6609994A (en) Analyte detection device and process
AU4853796A (en) Self-retracting medical needle apparatus and methods
EP0730245A3 (en) Digitizer and method of detecting positions
HUP9702463A3 (en) Process and compounds for the magnetorelaxometric detection of analytes and use thereof
AU5268696A (en) Novel compounds and methods for therapy
AU4859296A (en) Improved fiber filter and methods of use thereof
AU5175296A (en) Method of use of radicicol for treatment of inflammation and endotoxemia
AU8119794A (en) Method and means for prevention of cataract
AU3217795A (en) Apparatus and methods for cryogenic treatment of materials
AU7236696A (en) Method of treating insulin resistance
AU5965696A (en) Terpenoid-type quinones for treatment of diabetes
AUPN089295A0 (en) Treatment of diabetic neuropathy
AU7621496A (en) Microsensor and use of such microsensor
AU6160594A (en) Diabetes prevention and treatment
AU3730093A (en) Methods of treating diabetes
AU7644194A (en) Diagnosis of insulin-dependent diabetes
AU6896396A (en) Materials and methods for detection and treatment of insulin-dependent diabetes
AU5667896A (en) Tar-depleted liquid smoke and method of manufacture
AU1019699A (en) A medicine for treating algomenorrhea and the method of preparation thereof
AU6031696A (en) Furanoeremophilane and eremophilanolide sesquiterpenes for t reatment of diabetes
AU2704995A (en) Plasma treatment of polymeric materials to enhance immobilization of analytes thereto
AU6829696A (en) Treatment of solutions